Primary and secondary gliosarcoma: differences in treatment and outcome

References

• Galanis E, Buckner JC, Dinapoli RP, et al. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results. J Neurosurg 1998;89:425–30.
   PubMed Web of Science ®Google Scholar
• Meis JM, Martz KL, Nelson JS. Mixed glioblastoma and sarcoma: a clinicopathologic study of 6 radiation therapy oncology group cases. Cancer 1991;67:2342–9.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of tumours of the central nervous system. Revised 4th ed. Lyon: IARC Press; 2016.
   Google Scholar
• Raab P, Pilatus U, Hattingen E, et al. Spectroscopic characterization of gliosarcomas – do they differ from glioblastomas and metastases? J Comput Assist Tomogr 2016;40:815–9.
   PubMed Web of Science ®Google Scholar
• Oh JE, Ohta T, Nonoguchi N, et al. Genetic alterations in gliosarcoma and giant cell glioblastoma. Brain Pathol 2016;26:517–22.
   PubMed Web of Science ®Google Scholar
• Lee D, Kang SY, Suh YL, Jeong JY, Lee JI, Nam DH. Clinicopathologic and genomic features of gliosarcomas. J Neurooncol 2012;107:643–50.
   PubMed Web of Science ®Google Scholar
• Rodriguez FJ, Scheithauer BW, Jenkins R, et al. Gliosarcoma arising in oligodendroglial tumors (“oligosarcoma”): a clinicopathologic study. Am J Surg Pathol 2007;31:351–62.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Nitta M, Komori T, et al. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted. Neuropathology 2018;38:41–6.
   PubMed Web of Science ®Google Scholar
• Damodaran O, van Heerden J, Nowak AK, et al. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy. J Clin Neurosci 2014;21:478–81.
   PubMed Web of Science ®Google Scholar
• Adeberg S, Bernhardt D, Harrabi SB, et al. Radiotherapy plus concomitant temozolomide in primary gliosarcoma. J Neurooncol 2016;128:341–8.
   PubMed Web of Science ®Google Scholar
• Frandsen J, Orton A, Jensen R, et al. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database. J Neurosurg 2018;128:1133–8.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent NJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96.
   PubMed Web of Science ®Google Scholar
• Cachia D, Kamiya-Matsuoka C, Mandel JJ, et al. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol 2015;125:401–10.
   PubMed Web of Science ®Google Scholar
• Zhang G, Huang S, Zhang J, Wu Z, Lin S, Wang Y. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients. J Neurooncol 2016;127:355–62.
   PubMed Web of Science ®Google Scholar
• Kozak KR, Mahadevan A, Moody JS. Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome. Neuro Oncol 2009;11:183–91.
   PubMed Web of Science ®Google Scholar
• Ahmed FI, Abdullah KG, Durgin J, Salinas RD, O’Rourke DM, Brem S. Evaluating the association between the extent of resection and survival in gliosarcoma. Cureus 2019;11:e4374.
   PubMed Web of Science ®Google Scholar
• Castelli J, Feuvret L, Haoming QC, et al. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series. J Neurooncol 2016;129:85–92.
   PubMed Web of Science ®Google Scholar
• Srivastava H, Dewan A, Sharma SK, et al. Adjuvant radiation therapy and temozolomide in gliosarcoma: is it enough? Case series of seven patients. Asian J Neurosurg 2018;13:297–301.
   PubMedGoogle Scholar
• Han SJ, Yang I, Ahn BJ, et al. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer 2010;116:1358–66.
   PubMed Web of Science ®Google Scholar
• Rath GK, Sharma DN, Mallick S, et al. Clinical outcome of patients with primary gliosarcoma treated with concomitant and adjuvant temozolomide: a single institutional analysis of 27 cases. Indian J Cancer 2015;52:599–603.
   PubMed Web of Science ®Google Scholar
• Walker GV, Gilbert MR, Prabhu SS, Brown PD, McAleer MF. Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice. J Neurooncol 2013;112:83–9.
   PubMed Web of Science ®Google Scholar
• Kleihues P, Cavenee WK, World Health Organisation classification of tumours: pathology and genetics of tumours of the nervous system. 3th ed. Lyon: IARC Press; 2000.
   Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. World Health Organziation classification of tumours of the central nervous system. 4th ed. Lyon: IARC Press; 2007.
   Google Scholar
• Hermann EJ, Petrakakis I, Polemikos M, et al. Electromagnetic navigation-guided surgery in the semi-sitting position for posterior fossa tumours: a safety and feasibility study. Acta Neurochir 2015;157:1229–37.
   PubMed Web of Science ®Google Scholar
• Hong B, Wiese B, Bremer M, et al. Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme. Am J Clin Oncol 2013;36:261–8.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Krauss JK. Image-guided resection of small lesions in the cavernous sinus and Meckel's cave. Eur J Surg Oncol 2010;36:208–13.
   PubMed Web of Science ®Google Scholar
• Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma – with particular reference to bronchogenic carcinoma. Cancer 1948;1:634–56.
   Web of Science ®Google Scholar
• Weller M, Müller B, Koch R, Bamberg M, Krauseneck P. Neuro-oncology Working Group of the German Cancer Society. Neuro-oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. J Clin Oncol 2003;21:3276–84.
   PubMed Web of Science ®Google Scholar
• Han SJ, Yang I, Otero JJ, et al. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. J Neurosurg 2010;112:990–6.
   PubMed Web of Science ®Google Scholar
• Frandsen S, Broholm H, Larsen VA, et al. Clinical characteristics of gliosarcoma and outcomes from standardized treatment relative to conventional glioblastoma. Front Oncol 2019;9:1425.
   PubMed Web of Science ®Google Scholar
• Chen B, Liu B, Wu C, Wang Z. Prognostic factors among single primary gliosarcoma cases: a study using surveillance, epidemiology, and end results data from 1973 to 2013. Cancer Med 2019;8:6233–42.
   PubMed Web of Science ®Google Scholar
• Lutterbach J, Guttenberger R, Pagenstecher A. Gliosarcoma: a clinical study. Radiother Oncol 2001;61:57–64.
   PubMed Web of Science ®Google Scholar
• Jin MC, Liu EK, Shi S. Evaluating surgical resection extent and adjuvant therapy in the management of gliosarcoma. Front Oncol 2020;10:337
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang J, Liu M, You C. Treatments of gliosarcoma of the brain: a systematic review and meta-analysis. Acta Neurol Belg 2020;6. 10.1007/s13760-020-01533-w.
   Web of Science ®Google Scholar
• Huang Q, Li F, Chen Y, Hong F, Wang H, Chen J. Prognostic factors and clinical outcomes in adult primary gliosarcoma patients: a surveillance, epidemiology, and end results (SEER) analysis from 2004 to 2015. Br J Neurosurg 2019;12:1–7.
   Google Scholar
• Ortega A, Sarmiento JM, Ly D, et al. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era. J Clin Neurosci 2016;24:105–11.
   PubMed Web of Science ®Google Scholar
• Robin AM, Lee I, Kalkanis SN. Reoperation for recurrent glioblastoma multiforme. Neurosurg Clin N Am 2017;28:407–28.
   PubMed Web of Science ®Google Scholar
• Kakkar N, Kaur J, Singh GK, Singh P, Siraj F, Gupta A. Gliosarcoma in young adults: a rare variant of glioblastoma. World J Oncol 2017;8:53–7.
   PubMedGoogle Scholar
• Smith DR, Wu CC, Saadatmand HJ, et al. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma. J Neurooncol 2018;137:303–11.
   PubMed Web of Science ®Google Scholar
• Hong B, Polemikos M, Heissler HE, Hartmann C, Nakamura M, Krauss JK. Challenges in cerebrospinal fluid shunting in patients with glioblastoma. Fluids Barriers CNS 2018;15:16.
   PubMed Web of Science ®Google Scholar
• Guerriero A, Giovenali P, La Starza R, et al. Metachronous cardiac and cerebral sarcomas: case report with focus on molecular findings and review of the literature. Hum Pathol 2015;46:482–7.
   PubMed Web of Science ®Google Scholar
• Salvati M, Caroli E, Raco A, Giangaspero F, Delfini R, Ferrante L. Gliosarcomas: analysis of 11 cases do two subtypes exist? J Neurooncol 2005;74:59–63.
   PubMed Web of Science ®Google Scholar
• Han SJ, Yang I, Tihan T, Prados MD, Parsa AT. Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol 2010;96:313–20.
   PubMed Web of Science ®Google Scholar
• Singh G, Das KK, Sharma P, et al. Cerebral gliosarcoma: analysis of 16 patients and review of literature. Asian J Neurosurg 2015;10:195–202.
   PubMedGoogle Scholar
• Pierscianek D, Ahmadipour Y, Michel A, et al. Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma. Clin Neurol Neurosurg 2020;1:106348.
   Web of Science ®Google Scholar